Walden Catalyst — 2022 Investments
6 investments dated 2022 · listed companies and verified rows first · show all
Peptone develops a product engine to design small-molecule drug candidates targeting intrinsically disordered proteins, which have been difficult to address with conventional drug discovery approaches.
AI & Machine LearningBiotechDeep TechBellinzona, CH
Kamil Tamiola(Founder)in
Co-investorsBessemer Venture PartnersHoxton VenturesF-Prime CapitalFounders FactoryFounders Factory NYNovartis Venture Fund
AI21 develops trustworthy artificial intelligence technology to enhance human productivity.
AI & Machine LearningDeveloper ToolsEnterprise Software
Ori Goshen(Founder)inYoav Shoham(Founder)inAmnon Shashua(Founder)in
Co-investors8VCAhren Innovation CapitalCoatue ManagementComcast VenturesFelicis VenturesIntel Capital+8 more
Building the AI hardware industry from scratch
Jovan Stojanovic(Founder)in
Co-investorsEntrada VenturesTensor VenturesAcequia Capital (AceCap)Earlybird Venture Capital
OPAQUE provides a hardware-enforced trust layer for AI systems that enables organizations to run AI on sensitive data with independently verifiable proof of data protection.
AI & Machine LearningCybersecurityEnterprise SoftwareSan Francisco, US
Ion Stoica(Co-Founder)inRaluca Ada Popa(Co-Founder)inRishabh Poddar(Co-Founder and CTO)inChester Leung(Co-Founder)inWenting Zheng(Co-Founder)inAaron Fulkerson(CEO)in
Co-investorsIntel CapitalStorm VenturesRace Capital
Cloud-based data integration for complex hardware engineering
Mountain View, US
Joshua Patterson(Founder)Keith Kraus(Founder)Darren Haas(Founder)Josh Patterson(Founder)Rodrigo Aramburu(Founder)Wes McKinney(Founder)
Co-investorsBattery VenturesCoatue ManagementFelicis VenturesGV (Google Ventures)Lightspeed Venture PartnersAccenture Ventures+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

























